Smart Check – COVID‐19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS‐CoV‐2 infection in a public health service

Anschau, Fernando; Worm, Paulo Valdeci; Kopittke, Luciane; Villwock, Luis Humberto de Mello; Sartori, M.; Rosário, Jéferson Cardoso do; Inácio, José Francisco Secorun; Much, Maicon Diogo; Marckmann, Eduardo; Pinheiro, Sandro; Vissoci, João Ricardo Nickenig; Machado, Wagner de Lara; Costa, Dalton Breno; Klug, Daniel; Prestes, Juliane Martin; Hessel, Fabiano

doi:10.1111/ijcp.14610

Cited by 5 publications

(3 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…7,8 The predictors of SARS-CoV-2 infection include contact history with confirmed cases, fever, respiratory symptoms, gustatory dysfunction, gastrointestinal symptoms, and neurological symptoms. [9][10][11][12] The results of laboratory examinations have also been studied to help construct a predictive model using artificial intelligence. 13 However, patients with early COVID-19 or certain groups of patients, such as pregnant women, may only experience mild symptoms or could even be asymptomatic.…”

Section: Introductionmentioning

confidence: 99%

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

Hsu¹,

Liu²,

Tseng³

et al. 2021

JMDH

View full text Add to dashboard Cite

Purpose:The COVID-19 pandemic poses a serious threat to healthcare workers and hospitalized patients. Early detection of COVID-19 cases is essential to control the spread in healthcare facilities. However, real-world data on the screening criteria for hospitalized patients remain scarce. We aimed to explore whether patients with negative results of prehospital screening for COVID-19 should be rescreened after admission in a low-prevalence (less than 3% of the world average) setting. Patients and Methods:We retrospectively included patients in central Taiwan who were negative at the first screening but were newly diagnosed with pneumonia or had a body temperature above 38 degrees Celsius during their hospitalization. Each patient might be included as an eligible case several times, and the proportions of cases who were rescreened for COVID-19 and those diagnosed with COVID-19 were calculated. A logistic regression model was constructed to identify factors associated with rescreening. Reverse transcriptionpolymerase chain reaction tests were used to confirm the diagnosis of COVID-19. Results: A total of 3549 cases eligible for COVID-19 rescreening were included. There were 242 cases (6.8%) who received rescreening. In the multivariable analysis, cases aged 75 years or older, those with potential exposure to SARS-CoV-2, or patients visiting specific departments, such as the Cardiovascular Center and Department of Neurology, were more likely to be rescreened. None was diagnosed with COVID-19 after rescreening. There was no known cluster infection outbreak in the hospital or in the local community during the study period and in the following two months. Conclusion:In Taiwan, a country with a low COVID-19 prevalence, it was deemed safe to rescreen only high-risk hospitalized patients. This strategy was effective and reduced unnecessary costs.

show abstract

Section: Introductionmentioning

confidence: 99%

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

Hsu¹,

Liu²,

Tseng³

et al. 2021

JMDH

View full text Add to dashboard Cite

show abstract

“…3 4 COVID-19 is a life-threatening infectious disease caused by SARS-CoV-2, whose clinical manifestations include fever, cough, dyspnoea, haemoptysis, headache, myalgia, diarrhoea, fatigue and decreased sense of smell. 5 It affects not only the respiratory system but also the cardiovascular, renal, gastrointestinal, endocrine, neurological and musculoskeletal systems, 6 and the elderly, obese individuals, and those with heart disease, immune-suppression, and pre-existing respiratory problems are more likely to develop severe forms of this disease. 7 It is highly infectious and has a high mortality rate.…”

Section: Introductionmentioning

confidence: 99%

Effects of tai chi and qigong on rehabilitation after COVID-19: a protocol for systematic review and meta-analysis

et al. 2022

View full text Add to dashboard Cite

IntroductionCOVID-19 is a public health emergency of international concern, which is characterised by rapid and widespread transmission, high mortality and complications. Several studies have shown the benefits of tai chi and qigong for recovery after COVID-19; however, no meta-analysis has been reported. Therefore, the purpose of this study is to evaluate the efficacy and safety of tai chi and/or qigong on rehabilitation after COVID-19 through a systematic review and meta-analysis to provide a reference and basis for clinical application.Methods and analysisThis study will use the Cochrane Library, PubMed, Web of Science, Embase, China Knowledge Network, China Biomedical Literature Database, Chinese Scientific Journal Database and Wanfang Database. The time period is from the inception of the database to November 2021, with no language restrictions. Searches will be conducted using the subject terms “Taichi”,“Qigong” and “COVID-19” plus free-text words. Articles will be screened and collected by two reviewers independently. Included studies will be assessed for quality using the Cochrane Risk of Bias Assessment Tool. Statistical analyses will be performed using the Revman V.5.3 software. The primary outcomes include 1-second forced expiratory volume and 1-second forced vital capacity, oxygen saturation, total white cell count and quality of life score. Secondary outcomes include time to remission of major symptoms, incidence of adverse events, clinical cure rate and mortality. Subgroup and sensitivity analyses will also be used to explore and interpret the heterogeneity. This protocol is written based on the guideline of the Preferred Reporting Items for Systematic Reviews and Meta-analyses Protocol.Ethics and disseminationEthical approval and consent are unnecessary because no primary data will be collected. The results will be disseminated through peer-reviewed publications.PROSPERO registration numberCRD42021288962.

show abstract

“…[2] As the number of confirmed cases and deaths in China and other countries surged, on March 11, 2020, the World Health Organization officially characterized COVID-19 as a pandemic sweeping the world. [3] COVID-19 not only includes common symptoms such as dry cough, fever, dyspnea, myalgia, and headache, [4][5][6] but also causes or aggravates, for example, pathologies in the central nervous system, [7][8][9] gastrointestinal tract, [10] heart, blood, liver, kidneys, and numerous other organs and tissues. [11][12][13][14] In addition, the clinical manifestations of novel coronavirus pneumonia are more pronounced in patients aged over 60 years, [15] whose treatment is more difficult, with a longer course and poorer healing, and therefore treatment and care of older adults over 60 years should be given more attention.…”

Section: Introductionmentioning

confidence: 99%

Efficacy and safety of Qi and Blood Tonic Chinese Medicines in the treatment of COVID-19: A protocol for systematic review and meta-analysis

Yang

Zhang

et al. 2022

Medicine

View full text Add to dashboard Cite

Background: Coronavirus disease in 2019 (COVID-19) is a sudden public event affecting all human beings, with the rapid transmission, extensive groups affected, many complications, and high mortality. Traditional Chinese Medicine has a long history of preventing and treating infectious diseases, and numerous studies have shown that Traditional Chinese Medicine, especially herbal medicine, has a positive effect on the prevention, treatment, and post-healing recovery of this COVID-19, and herbal medicines to supplement qi and blood often occupy a certain proportion of it. However, there is no relevant meta-analysis to date. Therefore, this study aims to evaluate the efficacy and safety of qi and blood tonic herbal medicines in the treatment of COVID-19 through Systematic Review and meta-analysis to provide a reference basis for widespread clinical application. Methods: We will search from the following databases for the period from the time of database construction to March 1st, 2023. The English databases include: PubMed, MEDLINE, EMBASE, Cochrane library, WOS, Google Scholar, and CENTRAL; The Chinese databases include: China National Knowledge Infrastructure, China Biomedical Literature Database, Technology Journal Database, and Wanfang. Randomized controlled trials in English or Chinese that include Chinese herbal medicines for tonifying Qi and Blood in the treatment of patients with COVID-19 will be included. Data were independently screened and collected by 2 investigators. The risk of bias for each trial was assessed using the Cochrane Risk of Bias Tool 2.0. RevMan 5.3 software was used for the meta-analysis of the data. Primary outcome indicators included cure, mortality, and exacerbation rates (change in disease severity category, patient admission to ICU, etc.). Secondary outcome indicators included recovery rate or duration of major symptoms (e.g., fever, cough, fatigue, and weakness, etc.), rate or duration of nucleic acid conversion for severe acute respiratory syndrome coronavirus-2, improvement or recovery of chest CT performance, length of hospital stay, and other adverse events. Results: This protocol adheres to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses-P guidelines to ensure clarity and completeness of reporting in all phases of the systematic review. Conclusion: This study will provide evidence regarding the efficacy and safety of Qi and Blood Tonic Chinese Medicines for the treatment of COVID-19. PROSPERO registration number: CRD42022361822 (https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42022361822).

show abstract

Smart Check – COVID‐19 triage system: Evaluation of the impact on the screening time and identification of clinical manifestations of SARS‐CoV‐2 infection in a public health service

Cited by 5 publications

References 9 publications

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

COVID-19 Screening for Hospitalized Patients: The Role of Expanded Hospital Surveillance in a Low Prevalence Setting

Effects of tai chi and qigong on rehabilitation after COVID-19: a protocol for systematic review and meta-analysis

Efficacy and safety of Qi and Blood Tonic Chinese Medicines in the treatment of COVID-19: A protocol for systematic review and meta-analysis

Contact Info

Product

Resources

About